Anti-inflammatory effect of fibrate protects from cisplatin-induced ARF. - Wikidata - awgldk - TriplyDB

Anti-inflammatory effect of fibrate protects from cisplatin-induced ARF.

Anti-inflammatory effect of fibrate protects from cisplatin-induced ARF.

http://www.wikidata.org/entity/Q46425691

about

Mechanisms of Cisplatin nephrotoxicity Attenuation of cisplatin-induced renal injury by inhibition of soluble epoxide hydrolase involves nuclear factor κB signaling Emerging therapeutic targets of sepsis-associated acute kidney injury.Cisplatin inhibits hippocampal cell proliferation and alters the expression of apoptotic genes.Pathogenesis of acute kidney injury: foundation for clinical practice.Immune mechanisms and novel pharmacological therapies of acute kidney injury.Rosiglitazone synergizes anticancer activity of cisplatin and reduces its nephrotoxicity in 7, 12-dimethyl benz{a}anthracene (DMBA) induced breast cancer rats.Anaphylatoxin C5a contributes to the pathogenesis of cisplatin-induced nephrotoxicity.Pathophysiology of cisplatin-induced acute kidney injury.Peroxisome proliferator-activated receptor α protects capillary pericytes in the retina.Involvement of PPAR nuclear receptors in tissue injury and wound repair Acute unilateral ischemic renal injury induces progressive renal inflammation, lipid accumulation, histone modification, and "end-stage" kidney disease Transgenic expression of proximal tubule peroxisome proliferator-activated receptor-alpha in mice confers protection during acute kidney injury Mitochondrial-targeted antioxidants represent a promising approach for prevention of cisplatin-induced nephropathy Reduced kidney lipoprotein lipase and renal tubule triglyceride accumulation in cisplatin-mediated acute kidney injury PPAR-α Agonist Fenofibrate Decreased RANTES Levels in Type 2 Diabetes Patients with Hypertriglyceridemia Mechanisms of disease: regulation of RANTES (CCL5) in renal disease.MicroRNA-21 promotes fibrosis of the kidney by silencing metabolic pathways Nitro-oleic acid protects the mouse kidney from ischemia and reperfusion injury A H 2 S Donor GYY4137 Exacerbates Cisplatin-Induced Nephrotoxicity in Mice.Proximal tubule PPARα attenuates renal fibrosis and inflammation caused by unilateral ureteral obstruction.Administration of dexamethasone protects mice against ischemia/reperfusion induced renal injury by suppressing PI3K/AKT signaling.Vascular Inflammation: A Novel Access Route for Nanomedicine Caloric Restriction Is More Efficient than Physical Exercise to Protect from Cisplatin Nephrotoxicity via PPAR-Alpha Activation Atorvastatin Decreased Circulating RANTES Levels in Impaired Glucose Tolerance Patients with Hypercholesterolemia: An Interventional Study.Peroxisome proliferator-activated receptor agonists modulate neuropathic pain: a link to chemokines?Cisplatin nephrotoxicity: a review of the literature.Toll-like receptor (TLR4) shedding and depletion: acute proximal tubular cell responses to hypoxic and toxic injury.Fenofibrate treatment enhances antioxidant status and attenuates endothelial dysfunction in streptozotocin-induced diabetic rats.Role of IL-1α in cisplatin-induced acute renal failure in mice.Attenuation of cisplatin nephrotoxicity by inhibition of soluble epoxide hydrolase.Effects of Wy14643 on hepatic ischemia reperfusion injury in rats.Inhibition of hydrogen sulphide formation reduces cisplatin-induced renal damage.The molecular mechanisms of the attenuation of cisplatin-induced acute renal failure by N-acetylcysteine in rats.ATP-sensitive potassium channel blockage attenuates cisplatin-induced renal damage: a novel molecular mechanism.WY14,643, a PPARalpha ligand, attenuates expression of anti-glomerular basement membrane disease.Early, but not late, treatment with human umbilical cord blood-derived mesenchymal stem cells attenuates cisplatin nephrotoxicity through immunomodulation.PPARγ-Coactivator-1α, Nicotinamide Adenine Dinucleotide and Renal Stress Resistance.

P2860

Q26996320-81DF7A37-35C2-4ACC-9DB7-A03173772632 Q28385015-90D85363-7F8A-44EC-8A79-1F996D3A1173 Q30300333-F5FC8CBD-1719-47BC-8731-5701423165EA Q30413236-4931C6F3-15DA-4B10-84CC-326138A17285 Q30425669-0BD3BC7F-F73D-4BEB-90F9-01E7B98B0D8A Q30434767-6D01966A-FA31-4B19-A9D1-63961C3BD593 Q33428310-E7FD1C52-F2BD-4C95-B576-D231234084FB Q33792047-94623850-6819-4EF0-BF4B-A69751BD77B9 Q34073302-DBB7D6FF-86ED-409E-9EAF-BBEAC5458D2E Q34302874-3F79461A-7BA9-4C6C-8B72-17837EF6EC3B Q34416422-01DE6E02-A281-4592-A807-62B7FD4C23D9 Q35601604-BC439E06-AA09-46C2-9A91-AB54896F23F2 Q35628316-00CD6D24-58FF-462D-8188-C66B99E54B95 Q35659099-309C048E-B543-4BFB-A9F1-C0076DEB6D4A Q36208901-F7617A05-956E-45B4-AB63-EA0EA11288F2 Q36668641-5D29CACB-357C-4AD2-B002-7485C1041EA4 Q36745404-BC9951DF-8D65-40DA-BD2E-82EB806F5A76 Q36901558-D55CD1BE-A7E1-4661-AB7D-7EC0A867441B Q36956739-A5CDA66F-58A5-40FA-BD48-F7F3646E6F60 Q37000218-81C6F682-170F-4CE8-84A1-5FA18ECF9856 Q37142522-6F37C247-C833-4FB1-AAE1-A15F5598D8D4 Q37277745-61E9C4DD-8DEC-46D4-B3F6-619637711E1C Q37397963-23EA3A97-8581-47AA-9E74-27A1AFE92DD3 Q37675476-B82A6DA0-EFB8-4DE2-BB9E-15B9E0C4B1F6 Q37737452-5A44EC95-A75D-45A4-9E19-7184EBBA51D9 Q38246264-48799531-B0A4-45B2-8982-AD8CFAE1C112 Q39223600-117F47C5-0947-4C95-899F-C602A58447FA Q40248648-40C05CB9-241F-4448-BB5A-DB7762B2FE62 Q41605028-8F793BB8-0646-4140-97D3-A6CB241530D4 Q42025525-ADEF4C25-4FC0-4E03-98F8-26BC6CDFB581 Q42589261-F4F7ABF0-BB54-4849-9A7D-9A192509482E Q42619953-8AB196DC-7E9E-4062-BBF9-EE04523C42FC Q42959201-604E7F8C-C449-4DF4-9773-CE48CE142692 Q45845862-051C6C63-4D18-4D2E-A1AF-2B5236211707 Q46609148-03168D05-3020-4683-872E-3A2506B72C96 Q46987669-F2E7D042-174A-4872-8AB6-9B95610362D8 Q50765097-17B7FDA4-4AC8-4F75-804E-556EFF392552 Q55031670-598590A2-00D0-406C-9EF5-C4AF932EAF50

P2860

Anti-inflammatory effect of fibrate protects from cisplatin-induced ARF.

http://www.wikidata.org/entity/Q46425691

description

2005 nî lūn-bûn

@nan

2005年の論文

@ja

2005年学术文章

@wuu

2005年学术文章

@zh

2005年学术文章

@zh-cn

2005年学术文章

@zh-hans

2005年学术文章

@zh-my

2005年学术文章

@zh-sg

2005年學術文章

@yue

2005年學術文章

@zh-hant

name

Anti-inflammatory effect of fibrate protects from cisplatin-induced ARF.

@en

Anti-inflammatory effect of fibrate protects from cisplatin-induced ARF.

@nl

type

label

Anti-inflammatory effect of fibrate protects from cisplatin-induced ARF.

@en

Anti-inflammatory effect of fibrate protects from cisplatin-induced ARF.

@nl

prefLabel

Anti-inflammatory effect of fibrate protects from cisplatin-induced ARF.

@en

Anti-inflammatory effect of fibrate protects from cisplatin-induced ARF.

@nl

P1433

Q46425691-EE03F70C-91EB-4B03-84E5-66ACCF3825C6

P1476

Q46425691-2B5ED8C8-0EC1-454D-A23F-8E49160C92EC

P2093

Q46425691-1D2DE284-ED33-43D0-91D9-5E9A3083F715

Q46425691-375D38E3-40DF-41A4-AB44-67A0D8AB51EB

Q46425691-AB4D6A2C-E362-4B01-8254-18F09FAD0EB2

Q46425691-EB68ED5A-F3A3-4C51-A8E5-BEE8E09BD1FB

P2860

Q46425691-098F7C51-F52A-4B9D-8716-8062ECD6B9D8

Q46425691-1B1556EE-0ED7-43CE-B9B8-998686E66F30

Q46425691-1B4BDA5C-2E54-4612-8851-7C4FA8719970

Q46425691-212E6872-90D9-48AA-8980-A0ADB360F578

Q46425691-29C6F277-8A1F-4688-86DA-923F255CEA98

Q46425691-2B26DB93-69D4-4B14-9872-E2FF0F6F6381

Q46425691-327EA723-8D7E-4C0E-8322-4428E490FDB4

Q46425691-34F52A06-B8A4-41E8-99F6-31D082BD2232

Q46425691-3B9B8488-1CBD-41EB-A713-DF686FC89D0E

Q46425691-3E866F4D-1F8C-4B3A-B434-D850DA65127D

P304

Q46425691-B486D14E-2AF6-40E2-8D93-2B176F6C9A28

P31

Q46425691-2138DBBB-F482-4075-A7E9-BFEE85D830EA

P356

Q46425691-529AC5FC-3C91-49C3-B3EB-925D49B484CE

P433

Q46425691-D12912BF-CA60-49C0-AFF8-047339E044BC

P478

Q46425691-C9F4789D-B1E3-4E05-8678-2DB8825921A8

P50

Q46425691-67B50D6C-73BE-4BDD-99F9-EF5921A20BAB

P577

Q46425691-BBECDA66-8F13-4BE6-9E95-1C4C1EBC2C18

P698

Q46425691-5E583881-F5D1-47D6-9C9B-D361A11E5EA0

P921

Q46425691-157AC83F-0AAD-4BC9-B9D0-776E7CD602EE

P356

AJPRENAL.00038.2005

P1433

American Journal of Physiology - Renal Physiology

P1476

Anti-inflammatory effect of fibrate protects from cisplatin-induced ARF.

@en

P2093

Didier Portilla

http://www.w3.org/2001/XMLSchema#string

Neriman Gokden

http://www.w3.org/2001/XMLSchema#string

Renu Bhatt

http://www.w3.org/2001/XMLSchema#string

Shenyang Li

http://www.w3.org/2001/XMLSchema#string

P2860

Molecular cloning, functional expression, and signaling characteristics of a C-C chemokine receptor

Isolation and characterization of cDNA from renal tubular epithelium encoding murine Rantes

Impaired host defense, hematopoiesis, granulomatous inflammation and type 1-type 2 cytokine balance in mice lacking CC chemokine receptor 1

The two NF-kappaB activation pathways and their role in innate and adaptive immunity

Peroxisome proliferator-activated receptors in inflammation control.

Emerging roles of PPARs in inflammation and immunity.

Chemokines and chemokine receptors in renal pathology.

Energy metabolism and cytotoxicity.

Inflammatory cells in ischemic acute renal failure.

Identification of the CD4(+) T cell as a major pathogenic factor in ischemic acute renal failure.

P304

F469-80

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1152/AJPRENAL.00038.2005

http://www.w3.org/2001/XMLSchema#string

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

289

http://www.w3.org/2001/XMLSchema#string

P50

P577

2005-04-05T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

15814532

http://www.w3.org/2001/XMLSchema#string

P921